Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 17, 2018

VPR Staff Editor

Kathy Kyler is the staff editor for the OUHSC campus. Her assistance is available on request without

charge through the office of the Vice President for Research. You can contact her by e-mail at or by calling ORA at 271-2090. Please allow sufficient time for review.

In general, turnaround time is 7 business days for manuscripts and 5 business days for

grant proposals of 12 pages or less for the research plan.



Some DOD Deadlines are extended due to Hurricane Florence.  Please see the attached list.


Protecting Human Research Participants (PHRP) Online Tutorial No Longer Available

as of September 26, 2018

We recently released a policy notice (

announcing that as of September 26, 2018, the NIH will no longer be offering the Protecting Human

Research Participants (PHRP) course. Users should be sure to complete any in-progress courses and/or

print their course certificate before this date.

It is important to note that investigators are still required to comply with all aspects of the NIH policy 

Required Education in the Protection of Human Research Participants (, 

and can do so through a different training program or course. NIH does not plan to offer an alternative course.

Archived course content will be available as a reference in PDF format on the NIH Research Involving Human  

Subjects website.

Be sure to check out our frequently asked questions page (

for more information on the protection of human subjects education requirement.




The National Science Foundation (NSF) announces the launch of the NSF 2026 Idea Machine, a

prize competition to help set the U.S. agenda for fundamental research in science, technology,

engineering, and mathematics (STEM) and STEM education. Participants can earn cash prizes and

receive public recognition by suggesting the pressing research questions that need to be answered

in the coming decade, the next set of “Big Ideas” for future investment by NSF. It's an opportunity

for researchers, the public and other interested stakeholders to contribute to NSF's mission to

support basic research and enable new discoveries that drive the U.S. economy, enhance national

security and advance knowledge to sustain the country's global leadership in science and engineering.

Entries will be accepted through October 26, 2018. For more information, including entry instructions,

eligibility, rules, and judging criteria, please visit the



The Office of Technology Development will offer the Innovation to Impact Series

Session 2 “Align Your Research With Industry.” You will explore: How to gather useful insights

from the market, Common customer discovery mistakes, and Funding to support market discovery.

This session will occur on September 26th  from Noon- 1:00 pm in Biomedical Research Center Building,  

Room 103. Lunch will be provided.

Please RSVP to by September 20th. Space is limited to the first 15 attendees.



NIH UPDATE!! Effective immediately, Just-in-Time requests for information require

completion of a Foreign Involvement Section. 

This requires the PI to verify the following:

1.    collaborator’s name (IF NOT PROVIDED)

2.    name and address of the foreign site; (IF NOT PROVIDED IN SF424)

3.    estimated total costs of the foreign component/site (if/any) for each year;

4.    brief narrative that includes description of the work that will be performed at each foreign site.

5.    the involvement of human subjects or animals;

6.    extensive foreign travel by grantee project staff for the purpose of data collection, surveying,

                          sampling, and similar activities;

7.    any activity that may have an impact on U.S. foreign policy through involvement in the affairs of

                          environment of a foreign country;

8.    collaboration with investigators at foreign site anticipated to result in co-authorship

9.    use of facilities or instrumentation be used at foreign site;

10.    receipt of financial support or resources from a foreign entity.

There are additional requirements for NIH-funded institutions regarding foreign influence and partners.  

We will provide more information as it becomes available.



Federal Websites that will satisfy the Revised Common Rule’s requirement to

post clinical trial consent forms (45 CFR 46.116(h)) - The U.S. Department of Health and

Human Services (HHS) and 16 other federal departments and agencies are announcing where

clinical trial consent forms can be posted, as will be required by the revised Common Rule. No

obligations to post such consent forms apply before January 21, 2019. 
The revised Common Rule requires that for any clinical trial conducted or supported by a Common

Rule department or agency, one consent form be posted on a publicly available federal website

within a specific time frame.  The consent form must have been used in enrolling participants in

order to satisfy this new provision.  You can read more information about the revised Common Rule

on the OHRP website (
At this time, two publicly available federal websites that will satisfy the consent form posting requirement,

as required by the revised Common Rule, have been identified: and a docket folder on (Docket ID: HHS-OPHS-2018-0021).  HHS and other Common Rule departments and

agencies are developing instructions and other materials providing more information to the regulated

community about this posting requirement. 


Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS

The abstract submission deadline for the HHDC 2018 Research Symposium is Friday, October 5th

Abstracts must be received by 5 p.m. HHDC 2018 Research Symposium will be held on Friday,

November 16, 2018 at the Samis Education Center in Children’s Hospital in Oklahoma City. The

Symposium will consist of selected oral presentations, a poster session, and Symposia talks by

Silvia Corvera, MD, Professor, University of Massachusetts Medical School, Timothy McGraw PhD,

Professor, Cornell Weill College of Medicine and Morris White, PhD, Professor, Harvard University. 

For abstract submission guidelines and to RSVP for this free event, please go to:  Please contact 

with any questions for this event.



NOW ACCEPTING APPLICATIONS – Funding to complete the Master of Science degree

in Clinical and Translational Sciences

Now seeking applications for the NIMHD-funded research training and career development program. 

The goal of the program is to facilitate the education of participants from diverse backgrounds under-

represented in biomedical research to pursue clinical research or population health research on diseases

that disproportionately impact minority and rural populations in Oklahoma. 

The program provides two years of partial salary and research support to complete the Master of Science

degree in Clinical and Translational Sciences (MS in CTS) that is administered through the OUHSC

Graduate College.  To be eligible, applicants must hold a clinical doctoral degree or PhD, be from a

group underrepresented in biomedical research (racial and ethnic groups that have been shown by the

National Science Foundation to be underrepresented in biomedical research or individuals with disabilities),

be within seven years of their first faculty appointment, AND plan to pursue a research career focused on

minority health or health disparities research.  The 2-year program covers 50% protected time (salary+fringe),

tuition and fees for the MS in CTS degree program, travel to professional meetings, and modest research funds.

Applications are due 10/15/18.  Application materials can be found at:

For additional information, please contact Julie Stoner, PhD (



END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer Conference

Dates: December 6-7, 2018

Location: Samis Education Center

Registration and Call for Abstracts:

Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude in the

afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in the areas of

nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of

cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new

and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.

Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery and

applications, biological and non-biological systems as carriers and therapeutics, molecular imaging, biomimetics,

immune-oncology, toxicology and clinical trials.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists,

chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals,

educators and technology transfer specialists. Students and fellows will have an opportunity to present their

work as a poster presentation and compete for awards.



The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational

Resources (OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP)

Grants Program. The purpose of the program is to provide funding for collaborative and/or multi-disciplinary

clinical and translational pilot projects between investigators of the OSCTR member institutions.

The program seeks to support proposals designed to generate preliminary data that will result in improved health

and/or healthcare for citizens of Oklahoma and other IDeA states and enhance the competitiveness of the

investigators for future extramural funding. The program also seeks to fund innovative concepts, approaches, and

methodologies that bring fresh new ideas to solving the health issues of those living in Oklahoma and collaborating

IDeA states. Projects that focus on the medically underserved and on health concerns prevalent within Oklahoma

and our OSCTR partners will be a priority. Only projects which meet the NIH definition of clinical and/or translational

research will be accepted. Proposals are due September 21, 2018.  More information can be found at


i2E Entrpreneurial Summit

This annual entrepreneurial event will give you tips, tricks and strategies for entrepreneurs.

Hear from local successful entrepreneurs as they share their personal stories on how they

got started, their successes and their failures. To be held Friday, September 28, 2018.

See attachment for additional information and registration.




Clarification: Fixed Amount Award Definition and Implementation for Clinical Trials (NOT-OD-18-222)


Additional Awards Eligible for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research

(Admin Supp) (NOT-OD-18-226)


Pre-Solicitation Notice: Patient Safety Monitoring in International Laboratories (SMILE) (NOT-AI-18-059)


Notice of Termination of PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity  

Research Experiences (R25)" (NOT-CA-18-105)


Notice of Termination of PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity

Courses for Skills Development (R25)" (NOT-CA-18-106)


Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid

Innovation Network Clinical Research Sites (NOT-DA-18-034)


Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid

Innovation Network Coordination and Translation Center (NOT-DA-18-035)


Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid

Innovation Network Advanced Analytics and Methodology Center (NOT-DA-18-036)


Notice of Added Research Goals for RFA-DA-19-005 "Science-Based Quality Measurement and

Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)"



Request for Proposals (RFP) Notice: Quantification of Drugs of Abuse and Related Substances in

Biological Specimens (NOT-DA-18-063)


Notice of Extension of Expiration Date for PAR-15-344 "NIDCR Small Research Grants for Oral Health

Data Analysis and Statistical Methodology Development (R03) (NOT-DE-18-020)


Notice of Changes to NICHD Acceptance of Diversity and Re-Entry Supplement Applications



Request for Information (RFI): Soliciting Input for future research at the National Heart, Lung, and

Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in

patients with Hemophilia A (NOT-HL-18-652)


Request for Information (RFI): Current Clinical Management and Assessment Practices in Lung

Transplantation (NOT-HL-18-653)


Notice of Key Date Changes for RFA-MD-18-010 " Technologies for Improving Minority Health and

Eliminating Health Disparities (R41/R42- Clinical Trial Optional)" (NOT-MD-18-014)


NIMHD Loan Repayment Program Technical Assistance Webinar (NOT-MD-18-015)


Notice of Extension of the Expiration Date for RFA-MH-18-707 "Confirmatory Efficacy Clinical Trials

of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)"



Notice of Extension of the Expiration Date for RFA-MH-18-701 "Clinical Trials to Test the Effectiveness

of Treatment, Preventive and Services Interventions (R01 Clinical Trial Required)" (NOT-MH-18-049)


Notice of Extension of the Expiration Date for RFA-MH-18-700 "Clinical Trials to Test the Effectiveness

of Treatment, Preventive and Services Interventions (Collaborative R01 Clinical Trial Required)"



Notice of Correction of PA-18-871, "BRAIN Initiative: Development Optimization, and Validation of

Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 Clinical Trial Not

Allowed)" (NOT-MH-18-051)


Notice of Pre-Application Webinar for the NIH Common Fund Acute to Chronic Pain Signatures

Program (NOT-RM-18-021)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids

(R01 Clinical Trial Not Allowed) (RFA-DA-19-009) – Deadline December 18, 2018


Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids

(R21-Clinical Trials Not Allowed) (RFA-DA-19-010) – Deadline December 18, 2018


Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)

Clinical Trial Not Allowed (PA-18-914) – Deadline November 5, 2018


Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial

Not Allowed) (PAR-18-911) – Deadline November 14, 2018


U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) (PAR-18-912)

Deadline November 8, 2018


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection

Research (U01 Clinical Trial Not Allowed) (PAR-18-913) – Deadline February 11, 2019